Jpmorgan Chase & CO KYVERNA THERAPEUTICS INC Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025
Number of Shares
39,502
Previous 2,166,437 98.18%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
N/A
-2,126,935 Reduced 98.18%
39,502 $0
Q4 2024

Feb 12, 2025
SELL
N/A
-220,915 Reduced 9.25%
2,166,437 $0
Q3 2024

Dec 26, 2024
BUY
N/A
326,095 Added 15.82%
2,387,352 $0
Q3 2024

Nov 08, 2024
BUY
N/A
326,095 Added 15.82%
2,387,352 $0
Q2 2024

Dec 26, 2024
SELL
N/A
-326,095 Reduced 13.66%
2,061,257 $0
Q2 2024

Aug 12, 2024
BUY
N/A
1,216,792 Added 144.09%
2,061,257 $0
Q1 2024

Dec 26, 2024
SELL
N/A
-1,542,887 Reduced 64.63%
844,465 $0
Q1 2024

May 10, 2024
BUY
N/A
844,465 New
844,465 $0
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email